跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 614 条关于
“AP-diABZI”
全部
614
临床试验
243
药物
262
机构
6
资讯
103
去年
Nanobody Platform Enhances Cancer Immunotherapy Through Albumin Hitchhiking and STING Activation
去年
Algiax's AP-325 Shows Promise in Phase 2a Trial for Neuropathic Pain
去年
AL-S Pharma Reports Positive Phase 2 Results for AP-101 in ALS Treatment
9个月前
Aprogen's Herceptin Biosimilar AP-063 Advances to Regulatory Approval Without Phase 3 Trials
4个月前
Delos Capital and AP Biosciences Launch Strategic Partnership to Accelerate Next-Generation Antibody Development
4年前
Mercury Biomed Receives $1.5M NIH Grant for WarmSmart Surgical Warming Device
前天
FDA Grants Breakthrough Therapy Designation to Armata's Phage Therapy AP-SA02 for Complicated S. aureus Bacteremia
5个月前
AP Biosciences and Tasly Amend Collaboration to Accelerate Global Development of Dual-Target Cancer Therapy AP505
6个月前
AL-S Pharma's AP-101 Shows Clinically Meaningful Disease Modification and Prolonged Survival in ALS Phase 2 Trial
9个月前
AL-S Pharma's AP-101 Shows Promising Survival Benefits in Phase 2 ALS Trial, Advancing to Phase 3
第 1 页,共 11 页
上一页
下一页